Revelation Biosciences, Inc.(REVB)
Biotechnology
Immunology & Autoimmune Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-12-12 | TIDMARSH GEORGE F Director | Sale | -27,771 | -39.75%42,096 | $0.52 | $14,438 | View SEC filing | |
| 2023-10-18 | TIDMARSH GEORGE F Director | Sale | -1,845 | -6.23%27,771 | $0.65 | $1,199 | View SEC filing | |
| 2023-10-17 | TIDMARSH GEORGE F Director | Sale | -10,957 | -20.65%42,096 | $0.66 | $7,243 | View SEC filing | |
| 2023-10-02 | TIDMARSH GEORGE F Director | Sale | -1,429 | -3.28%42,096 | $0.69 | $986 | View SEC filing | |
| 2023-09-18 | TIDMARSH GEORGE F Director | Sale | -25,500 | -39.32%39,348 | $0.74 | $18,895 | View SEC filing | |
| 2023-04-19 | TIDMARSH GEORGE F Director | Purchase | +51,500 | +385.83%64,848 | $1.16 | $59,740 | View SEC filing | |
| 2022-02-28 | TIDMARSH GEORGE F Director, 10% Owner | Purchase | +20,000 | +4.47%467,156 | $1.60 | $32,000 | View SEC filing | |
| 2022-02-10 | TIDMARSH GEORGE F Director, 10% Owner | Purchase | +31,000 | +7.45%447,156 | $2.55 | $79,139 | View SEC filing | |
| 2022-02-09 | TIDMARSH GEORGE F Director, 10% Owner | Purchase | +52,000 | +2.75%1,939,491 | $2.56 | $132,936 | View SEC filing | |
| 2022-02-08 | TIDMARSH GEORGE F Director, 10% Owner | Purchase | +50,000 | +3.39%1,523,335 | $2.56 | $128,036 | View SEC filing | |
| 2021-09-23 | GLAZER CAPITAL, LLC 10% Owner | Sale | -654,546 | -63.20%381,106 | $10.08 | $6,597,824 | View SEC filing | |
| 2020-11-12 | GLAZER CAPITAL, LLC 10% Owner | Sale | -5,000 | -0.48%1,035,652 | $10.00 | $50,000 | View SEC filing | |
| 2020-10-19 | GLAZER CAPITAL, LLC 10% Owner | Sale | -9,348 | -0.89%1,040,652 | $10.00 | $93,480 | View SEC filing |
1-13 of 13